HomeInsightsMarket Capitalization

Market Capitalization of Glaxosmithkline Pharmaceuticals Ltd

Market Capitalization of Glaxosmithkline Pharmaceuticals Ltd

stocks purchased

₹ 0.8 Cr

Volume Transacted

(Nov 22, 2024)

stocks purchased

3.4 K

Stocks Traded

(Nov 22, 2024)

Last Updated on: Nov 23, 2024

Image

Glaxosmithkline Pharmaceuticals Ltd

NSE: GLAXO

Market Cap

₹ 40914.95 crore

Last updated on: Nov 22, 2024

Key Highlights

  • The Market Cap of Glaxosmithkline Pharmaceuticals Ltd is ₹ 40914 crore as of 22 Nov 24 .
  • The Market Cap of Glaxosmithkline Pharmaceuticals Ltd changed from ₹ 22020 crore on March 2019 to ₹ 32917 crore on March 2024 . This represents a CAGR of 6.93% over 6 years.
  • The Latest Trading Price of Glaxosmithkline Pharmaceuticals Ltd is ₹ 2415 as of 22 Nov 15:30 .
  • The Dividend Payouts of Glaxosmithkline Pharmaceuticals Ltd changed from ₹ 30 on Jul 19, 2021 to ₹ 12 on Nov 07, 2024 . This represents a CAGR of -14.16% over 6 years.

Historical Market Cap of Glaxosmithkline Pharmaceuticals Ltd

No data available

* All values are in crore

Company Fundamentals for Glaxosmithkline Pharmaceuticals Ltd

No data available

Image

Glaxosmithkline Pharmaceuticals Ltd

NSE: GLAXO

Share Price

₹ 2415.2

44.00 (1.86%)

stock direction

Last updated on: Nov 22, 2024

Market Price of Glaxosmithkline Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Glaxosmithkline Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
22 Nov 20242415.2
21 Nov 20242371.2
19 Nov 20242436.25
18 Nov 20242412.25
14 Nov 20242456.7
13 Nov 20242453.35
12 Nov 20242547
11 Nov 20242537.55
08 Nov 20242555.15
07 Nov 20242610.25

SWOT Analysis Of Glaxosmithkline Pharmaceuticals Ltd

Strength

2

S

Weakness

1

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Glaxosmithkline Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Glaxosmithkline Pharmaceuticals Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of Market Cap

Key Valuation Metric of Glaxosmithkline Pharmaceuticals Ltd

No data available

No data available

Historical P/E Ratio of Glaxosmithkline Pharmaceuticals Ltd

No data available

* All values are in %

Historical Revenue of Glaxosmithkline Pharmaceuticals Ltd

No data available

* All values are in crore

Historical EBITDA of Glaxosmithkline Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Glaxosmithkline Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Dividend Payouts of Glaxosmithkline Pharmaceuticals Ltd

No data available

* All values are in

About Glaxosmithkline Pharmaceuticals Ltd

  • GlaxoSmithKline Pharmaceuticals Limited is a subsidiary of UK-based GSK Plc., a global biopharma company to unite science, technology and talent to get ahead of disease together.
  • The Company is headquartered in Mumbai and it has six branch offices, a manufacturing facility at Nashik in Maharashtra, 22 contract manufacturing organisations (CMOs) with regional and sales hubs across India.
  • The Company is engaged interalia, in the business of manufacturing, distributing and trading in pharmaceuticals. The Company's portfolio includes General Medicines, Vaccines and Specialty medicines that help prevent and treat disease.
  • Their prescription medicines range across therapeutic areas, such as Anti-Infectives, Dermatology, Gynaecology, Diabetes, Oncology, Cardiovascular Disease and Respiratory Diseases.

Glaxosmithkline Pharmaceuticals Ltd News Hub

News

GSK Pharma gains as Q2 PAT rises 15% YoY to Rs 249 cr

Profit before exceptional item and tax was at Rs 338.70 crore in the September 2024 quarte...

Read more

30 Oct 202410:39

News

Board of GlaxoSmithKline Pharmaceuticals recommends Special Interim Dividend

GlaxoSmithKline Pharmaceuticals announced that the Board of Directors of the Company at it...

Read more

29 Oct 202416:10

News

GlaxoSmithKline Pharmaceuticals to declare Quarterly Result

GlaxoSmithKline Pharmaceuticals will hold a meeting of the Board of Directors of the Compa...

Read more

25 Oct 202410:38

News

GSK Pharma Q1 PAT climbs 39% YoY to Rs 182 crore

Revenue from operations grew by 9.89% year on year (YoY) to Rs 811 crore during the quarte...

Read more

03 Aug 202412:25

News

GlaxoSmithKline Pharmaceuticals to convene board meeting

GlaxoSmithKline Pharmaceuticals will hold a meeting of the Board of Directors of the Compa...

Read more

18 Jul 202410:38

News

Glaxosmithkline Pharmaceuticals announces change in senior management

Glaxosmithkline Pharmaceuticals announced that Dr. Shalini Menon has been appointed as Exe...

Read more

05 Jul 202413:26

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for Glaxosmithkline Pharmaceuticals Ltd Market Cap

What is the market cap of Glaxosmithkline Pharmaceuticals Ltd?

As of November 23, 2024, Glaxosmithkline Pharmaceuticals Ltd has a market capitalization of ₹40914.95, however, this figure is subject to change due to fluctuations in its stock price and market conditions.

What factors influence Glaxosmithkline Pharmaceuticals Ltd's market capitalization?

Glaxosmithkline Pharmaceuticals Ltd's market capitalization is influenced by factors such as its financial performance, and the company’s ability to innovate and adapt to market trends. Moreover, macroeconomic factors like economic conditions, currency fluctuations, and global automotive industry trends also affect its market capitalization.

Can market capitalization be used to predict future stock performance of Glaxosmithkline Pharmaceuticals Ltd?

Market capitalization alone is not a reliable predictor of future stock performance, as it reflects the current value of a company's equity rather than its future potential. To forecast %s's future stock performance, investors should consider additional factors such as financial health, growth prospects, industry trends, and broader economic conditions.

How often does Glaxosmithkline Pharmaceuticals Ltd's market capitalization change?

Glaxosmithkline Pharmaceuticals Ltd's market capitalization can change frequently, within a single trading day, due to fluctuations in stock price. These changes are influenced by market conditions, investor sentiment, company performance, and broader economic factors. Therefore, tracking its market capitalization requires continuous monitoring of stock price movements and related financial news.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*